bluebird bio, Inc (BLUE) Bozor kapitallashuvining balans qiymatiga nisbati

bluebird bio Inc. (BLUE) - korporativ logo

bluebird bio, Inc. rahbariyati qimmatbaho gen terapiyalarini bozorga chiqarish bilan birga, qat'iy xarajatlarni kamaytirish choralariga e'tibor qaratmoqda. Bozor qiymatining kitob kapitalizatsiyasi koeffitsiyentidagi o'zgarish Lyfgenia va Skysona sotuvlarini hamda terapiyani kengaytirishga qaratilgan klinika sherikliklari tufayli yuzaga kelgan burilish nuqtasini namoyish etadi. Joriy qiymat -0.83 miqdorida qayd etilgan bo'lib, bu emitentning likvidligi va aktivlarining bozor bahosini tasdiqlaydi.

bluebird bio, Inc (BLUE) Kapitallashuvning balans qiymatiga nisbati: 04.07.2022 - 07.06.2025 davri uchun

bluebird bio Inc. (BLUE) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi bluebird bio, Inc.|BLUE - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Bluebird Bio|BLUE - Biznes qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya uchun sof aktivlar bluebird bio|BLUE - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati bluebirdbio.com|BLUE - Kompaniyaning umumiy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati bluebird bio, Inc.|BLUE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Bluebird Bio|BLUE - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Bluebird Bio|BLUE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari bluebird bio
Fundamental baholash:bluebird bio, Inc., BLUE
Bluebird Bio yetakchi tovari

Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlari bilan solishtirib, brend uchun to'langan premiumni yoki aktivlarning past baholanganligini aniqlaydi. Investor kompaniya qiymatining uning kitob kapitalizatsiyasiga nisbatdagi joriy koeffitsientini tahlil qilish orqali spekulyativ vasvasani haqiqiy fundamental barqarorlikdan ajratadi. Ushbu metrikaning o'sishi bozorning kelajakdagi daromadlariga bo'lgan ishonchini tasdiqlaydi. bluebird bio, Inc. (BLUE) uchun ushbu muvozanat xorijiy patentlarga bog'liqligi sababli juda muhimdir. Geopolitik risklar va biokomponentlar importiga tegishli murakkabliklar aktivlar bahosiga bevosita ta'sir ko'rsatadi.

Raqobatchilar tahlili

TEM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti qiagen.com (QGEN)|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|Beam Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|SRPT: Bozor qiymatining balans qiymatiga nisbati|Twist Bio (TWST) - Bozor qiymatining balans qiymatiga nisbati|TXG (10x) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati NTLA|Bozor kapitallashuvining balans qiymatiga nisbati stoketherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati BLFS|WVE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati MAZE (Maze Tx)|Sionna Corp - Bozor qiymatining balans qiymatiga nisbati|Prime Medicine, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi tayshagtx.com TSHA|uniQure (QURE) - Bozor qiymatining balans qiymatiga nisbati|MeiraGTx Holdings - Balans qiymatiga nisbatan bozor qiymati|RGNX (Regenxbio) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati SLDB (Solid Corp)|Kapitallashuvning sof aktivlarga nisbati OCGN (Ocugen, Inc.)|PACB (pacb.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BNTC (Benitec Biopharma)|Design Therapeutics Inc - Bozor qiymatining balans qiymatiga nisbati|Rocket Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi 4D Molecular Corp FDMT|lexeotx.com (LXEO) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Korro Bio (KRRO)|Kapitallashuvning sof aktivlarga nisbati EDIT|SLN: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PRQR|Balans qiymatiga nisbatan bozor kapitallashuvi codexis.com|Bozor qiymatining balans qiymatiga nisbati Sangamo Therapeutics SGMO|NAUT: Kapitallashuvning balans qiymatiga nisbati|Metagenomi - Bozor kapitallashuvining balans qiymatiga nisbati|precisionbiosciences.com (DTIL) - Kapitallashuvning sof aktivlarga nisbati|GBIO (generationbio.com) - Kapitallashuvning sof aktivlarga nisbati|BOLD - Balans qiymatiga nisbatan bozor kapitallashuvi|XCUR (Exicure Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati IMNN|Bozor qiymatining balans qiymatiga nisbati Phio Pharmaceuticals (PHIO)|Bozor qiymatining balans qiymatiga nisbati MBIO (mustangbio.com)|TransCode Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Bionano Genomics Inc. BNGO|Applied DNA Sciences - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ImmunoPrecise Antibodies|OMGA: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati OMIC|Bozor qiymatining balans qiymatiga nisbati Regulus Therapeutics Inc|Kapitallashuvning balans qiymatiga nisbati SYRS (Syros Pharmaceuticals, Inc)|Bozor kapitallashuvining balans qiymatiga nisbati TBIO|Bozor kapitallashuvining balans qiymatiga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)